DK1620394T3 - Fremgangsmåde til krystallisering af guanidinumsalte - Google Patents

Fremgangsmåde til krystallisering af guanidinumsalte

Info

Publication number
DK1620394T3
DK1620394T3 DK04726856T DK04726856T DK1620394T3 DK 1620394 T3 DK1620394 T3 DK 1620394T3 DK 04726856 T DK04726856 T DK 04726856T DK 04726856 T DK04726856 T DK 04726856T DK 1620394 T3 DK1620394 T3 DK 1620394T3
Authority
DK
Denmark
Prior art keywords
crystallizing
guanidium salts
guanidium
salts
crystallizing guanidium
Prior art date
Application number
DK04726856T
Other languages
Danish (da)
English (en)
Inventor
Michael Kirschbaum
Ekkehard Bartmann
Dieter Bensinger
Alexander Haas
Ricky Lippert
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK1620394T3 publication Critical patent/DK1620394T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK04726856T 2003-05-06 2004-04-10 Fremgangsmåde til krystallisering af guanidinumsalte DK1620394T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10320016 2003-05-06
PCT/EP2004/003838 WO2004099125A1 (fr) 2003-05-06 2004-04-10 Procede pour cristalliser des sels de guanidinium

Publications (1)

Publication Number Publication Date
DK1620394T3 true DK1620394T3 (da) 2008-11-24

Family

ID=33426672

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04726856T DK1620394T3 (da) 2003-05-06 2004-04-10 Fremgangsmåde til krystallisering af guanidinumsalte

Country Status (19)

Country Link
US (1) US7629493B2 (fr)
EP (1) EP1620394B1 (fr)
JP (1) JP2006525247A (fr)
KR (1) KR20060015580A (fr)
CN (1) CN1784381A (fr)
AR (1) AR044252A1 (fr)
AT (1) ATE404533T1 (fr)
AU (1) AU2004235886B2 (fr)
BR (1) BRPI0410022A (fr)
CA (1) CA2524718A1 (fr)
DE (1) DE502004007841D1 (fr)
DK (1) DK1620394T3 (fr)
ES (1) ES2310725T3 (fr)
MX (1) MXPA05011840A (fr)
PL (1) PL1620394T3 (fr)
PT (1) PT1620394E (fr)
RU (1) RU2374224C2 (fr)
WO (1) WO2004099125A1 (fr)
ZA (1) ZA200509867B (fr)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975533A (en) 1970-04-29 1976-08-17 Shell Oil Company Therapeutic agents
US4113776A (en) * 1976-04-15 1978-09-12 Hoffmann-La Roche Inc. 1-(2-Aminoethyl)-3-(2,6-dihalophenyl)guanidines
JPS61129159A (ja) * 1984-11-28 1986-06-17 Nippon Zeon Co Ltd 保護化アミノ酸アミド化合物の精製法
DK0589336T3 (da) * 1992-09-22 1997-06-16 Hoechst Ag Benzylguanidiner, fremgangsmåde til deres fremstilling samt deres anvendelse som antiarytmetika
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4328352A1 (de) * 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4430916A1 (de) 1994-08-31 1996-03-07 Merck Patent Gmbh Alkyl-benzoylguanidin-Derivate
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE19529612A1 (de) * 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate
DE19737224A1 (de) * 1997-08-27 1999-03-18 Hoechst Marion Roussel De Gmbh Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen
DE19738604A1 (de) * 1997-09-04 1999-03-11 Hoechst Marion Roussel De Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verminderung der Giftigkeit cardiotoxischer Stoffe
US6147098A (en) * 1998-05-11 2000-11-14 Novo Nordisk A/S Substituted guanidines and diaminonitroethenes, their preparation and use
DE19951418A1 (de) * 1999-10-26 2001-05-03 Merck Patent Gmbh Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid

Also Published As

Publication number Publication date
WO2004099125A1 (fr) 2004-11-18
EP1620394B1 (fr) 2008-08-13
JP2006525247A (ja) 2006-11-09
AU2004235886B2 (en) 2010-07-01
ES2310725T3 (es) 2009-01-16
BRPI0410022A (pt) 2006-04-25
CN1784381A (zh) 2006-06-07
AR044252A1 (es) 2005-09-07
EP1620394A1 (fr) 2006-02-01
RU2374224C2 (ru) 2009-11-27
US7629493B2 (en) 2009-12-08
ZA200509867B (en) 2006-12-27
MXPA05011840A (es) 2006-01-26
PT1620394E (pt) 2008-11-24
CA2524718A1 (fr) 2004-11-18
US20070055064A1 (en) 2007-03-08
ATE404533T1 (de) 2008-08-15
KR20060015580A (ko) 2006-02-17
PL1620394T3 (pl) 2008-12-31
DE502004007841D1 (de) 2008-09-25
AU2004235886A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
DK1737461T3 (da) Carbolin-derivater til inhibering af angiogenese
DK2322511T3 (da) Fremgangsmåde til fremstilling af Telmisartan
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1575416T3 (da) Fremgangsmåder til diagnosticering af præeklampsi
DK2058243T3 (da) Fremgangsmåde til fremstilling af drikke
NO20054005D0 (no) Nye arylpiperazinylforbindelser
FI7526U1 (fi) Kiteinen bikalutamidi
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
NO20053687D0 (no) Crystallisation Process.
NO20053676D0 (no) Crystallisation Process
ATE404546T1 (de) Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen
DK2019118T3 (da) Fremgangsmåde til syntetisering af thymosiner
DK1869020T3 (da) Heteroarylureaderivater egnet til inhibering af CHK1
DK1963251T3 (da) Fremgangsmåde til fremstilling af aminer
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1682543T3 (da) Fremgangsmåde til fremstilling af nye tiotropiumsalte
ITMI20042238A1 (it) Composti per fluoropolirterei
DK1784183T3 (da) Fremgangsmåder til fremstilling af isothiazolderivater
DK1682541T3 (da) Fremgangsmåde til fremstilling af tiotropiumsalte
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
NO20055097D0 (no) Krystallinske N-formyl-hydroksylaminforbindelser
DK1937662T3 (da) Fremgangsmåde til fremstilling af duloxetin
DK1888613T3 (da) Fremgangsmåde til fremstilling af thiophenglycosidderivater
DK1692137T3 (da) Fremgangsmåde til fremstilling af tubulinininhibitorer